Recent reports have shown the UK recruitment industry has acquired more agencies than in the US. In a report by Ciett 2014 Economic Report it shows there are around 18,000 agencies in the UK compared to 17,000 in the states.
Moving into 2015, the HEOR and Market Access industry is looking to be one of movement with plenty of new opportunities arising from a talent acquisition point of view.
My name is Jessica and I’m the medical writing specialist here at Paramount Recruitment. I have over four years’ experience working with a range of medical and healthcare communication agencies across the UK, Europe and most recently internationally.
I have been working at Paramount Recruitment as the Operations Manager for almost 18 months, after previously spending almost 20 years within an outsourced contact centre.
Here at Paramount Recruitment we recently launched a survey asking our candidates what they think about the service we offer. We sent the survey to the candidates who have been submitted for a job in the past 12 months with a personal email from Talent Director and Co-founder Eugene McDaid…
Here at Paramount Recruitment, we recently launched a survey asking clients what their top 10 pet hates are when dealing with recruiters. Although we expected to see some of the answers, many of the pet hates were a bit of a shock to see…
It’s a very exciting time in the recruitment market – The REC are forecasting that the UK recruitment market will see accelerating growth with the first quarter growing at about 7% followed by the market picking up to above 8% across the latter part of 2014…
So it is an exciting time in the market place the REC anticipates 2014 being a year full of opportunity for the UK recruitment industry.
The debate over creating a centralized European medical device approval agency is still going strong. In large part, fueled by reactions to the PiP breast implant tragedy, many legislative groups are calling for a centralized standard throughout Europe controlled by one agency.
An agreement has been reached where Pfizer will be paying $491m (£320m) to settle a probe into illegal marketing of the drug, Rapamune by Wyeth, a company that was procured by Pfizer in 2009.
Cells from the main site of a tumour can circulate around the body via the bloodstream, causing the disease to spread.
Great Ormond Street Hospital in the UK has been the setting for research into the methods used to diagnose lung ailments in children. The study has revealed that healthy children of different ethnicities have different lung capacities.
How many of us actually read those little pieces of paper that accompany prescribed or over-the-counter medicine that people take every day. We rely on the fact that because the medication has been prescribed by a medical practitioner or pharmacist it should be safe and appropriate for a specific diagnosis.
By relocating the nucleus of a mature cell into an egg, scientists have for the very first time, developed human embryonic stem cells. According to stem cell biologist, George Daly at Children’s Hospital Boston and Harvard University, it is a huge landmark achievement.
A catalytic trigger has been identified by researchers as a factor in the origin of Alzheimer’s disease. This occurs when the basic make-up of a protein molecule alters, causing a chain reaction and resulting in the demise of neurons in the brain.